https://investor.ironwoodpharma.com/press-releases/press-release-details/2017/Ironwood-Announces-New-Drug-Application-for-DUZALLO-Fixed-Dose-Combination-of-Lesinurad-and-Allopurinol-Has-Been-Accepted-for-FDA-Review/default.aspx
https://investor.ironwoodpharma.com/press-releases/press-release-details/2017/Ironwood-Announces-New-Drug-Application-for-DUZALLO-Fixed-Dose-Combination-of-Lesinurad-and-Allopurinol-Has-Been-Accepted-for-FDA-Review/default.aspx